Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells

Cancer Letters

Volumn 303, Issue 1, 2011, Pages 39-46

  Jung, Hui Jung ^a   Suh, Seong Il ^a   Suh, Min Ho ^a   Baek, Won Ki ^a   Park, Jong Wook ^a  

^a Keimyung University   (South Korea)

Author keywords

Hypoxia inducible factor 1 ; Pentamidine; Protein translation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INITIATION FACTOR 4F; PENTAMIDINE; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RNA TRANSLATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PENTAMIDINE; PROSTATIC NEOPLASMS;

PROTOZOA;

EID: 79951850723     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.01.008     Document Type: Article

References (35)

1. Sands M., Kron M.A., Brown R.B. Pentamidine: a review. Rev. Infect. Dis. 1985, 7:625-634.
2. Goa K.L., Campoli-Richards D.M. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs 1987, 33:242-258.
3. Apted F.I. Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere. Pharmacol. Ther. 1980, 11:391-413.
4. Bryceson A.D., Chulay J.D., Mugambi M., Ware J.B., Gachihi G., Chung C.N., Muigai R., Bhatt S.M., Ho M., Spencer H.C., Meme J., Anabwani G. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:705-714.
5. Liu Y., Tidwell R.R., Leibowitz M.J. Inhibition of in vitro splicing of a group I intron of Pneumocystis carinii. J. Eukaryot. Microbiol. 1994, 41:31-38.
6. Zhang Y., Li Z., Pilch D.S., Leibowitz M.J. Pentamidine inhibits catalytic activity of Group I Intron Ca. LSU by altering RNA folding. Nucleic Acids Res. 2002, 30:2961-2971.
7. Sun T., Zhang Y. Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Res. 2008, 36:1654-1664.
8. Chow T.Y., Alaoui-Jamali M.A., Yeh C., Yuen L., Griller D. The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Mol. Cancer Ther. 2004, 3:911-919.
9. Pathak M.K., Dhawan D., Lindner D.J., Borden E.C., Farver C., Yi T. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol. Cancer Ther. 2002, 1:1255-1264.
10. Smith J., Stewart B.J., Glaysher S., Peregrin K., Knight L.A., Weber D.J., Cree I.A. The effect of pentamidine on melanoma. Anticancer Drug. 2010, 21:181-185.
11. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 2002, 8:S62-67.
12. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia and cancer. J. Mol. Med. 2007, 85:1301-1307.
13. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Jr Kaelin W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468.
14. Masson N., Willam C., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Embo J. 2001, 20:5197-5206.
15. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
16. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 2002, 277:38205-38211.
17. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000, 60:1541-1545.
18. Fukuda R., Kelly B., Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 2003, 63:2330-2334.
19. Liu X.H., Kirschenbaum A., Lu M., Yao S., Dosoretz A., Holland J.F., Levine A.C. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 2002, 277:50081-50086.
20. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.
21. Park J.Y., Park J.W., Suh S.I., Baek W.K. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells. Biochem. Biophys. Res. Commun. 2009, 382:96-101.
22. Mamane Y., Petroulakis E., LeBacquer O., Sonenberg N. mTOR, translation initiation and cancer. Oncogene 2006, 25:6416-6422.
23. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 2009, 10:307-318.
24. Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H., Sherman N.E., Pagano M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 2006, 314:467-471.
25. Zhu K., Chan W., Heymach J., Wilkinson M., McConkey D.J. Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression. Cancer Res. 2009, 69:1836-1843.
26. Semenza G.L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov. Today 2007, 12:853-859.
27. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metast Rev. 2007, 26:341-352.
28. Biekawski K., Galicka A., Bielawska A., Sredzinska K. Inhibitory effects of pentamidine analogues on protein biosynthesis in vitro. Acta. Biochim. Pol. 2000, 47:113-120.
29. Larsson O., Li S., Issaenko O.A., Avdulov S., Peterson M., Smith K., Bitterman P.B., Polunovsky V.A. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res. 2007, 67:6814-6824.
30. Graff J.R., Konicek B.W., Vincent T.M., Lynch R.L., Monteith D., Weir S.N., Schwier P., Capen A., Goode R.L., Dowless M.S., Chen Y., Zhang H., Sissons S., Cox K., McNulty A.M., Parsons S.H., Wang T., Sams L., Geeganage S., Douglass L.E., Neubauer B.L., Dean N.M., Blanchard K., Shou J., Stancato L.F., Carter J.H., Marcusson E.G. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J. Clin. Invest. 2007, 117:2638-2648.
31. Charpentier T.H., Wilder P.T., Liriano M.A., Varney K.M., Pozharski E., Mackerell A.D.Jr., Coop A., Toth E.A., Weber D.J. Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J. Mol. Biol. 2008, 382:56-73.
32. Markowitz J., Chen I., Gitti R., Baldisseri D.M., Pan Y., Udan R., Carrier F., Mackerell A.D.Jr., Weber D.J. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. J. Med. Chem. 2004, 47:5085-5093.
33. Fernandez-Fernandez M.R., Veprintsev D.B., Fersht A.R. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc. Natl. Acad. Sci. USA 2005, 102:4735-4740.
34. Lin J., Blake M., Tang C., Zimmer D., Rustandi R.R., Weber D.J., Carrier F. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem. 2001, 276:35037-35041.
35. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., Madan A., Semenza G.L., Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev. 2000, 14:34-44.